Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-005675

Options or other derivatives

  • President and CEO acquired 527,140 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Sanjiv President and CEO 2022-01-27 Grant or award · Stock Option (Right to Buy) +527,140 527,140 D
Loading xslF345X03/doc4.xml…